Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; Americas; and Asia. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $21.02 | N/A |
Market Cap | $2.85B | N/A |
Shares Outstanding | 135.45M | N/A |
Employees | 1.11K | N/A |